ZEN Graphene Solutions, formerly called Zenyatta Ventures, is a mineral exploration and development company based in Ontario, Canada. Zen is developing the Albany Graphite Deposit – a rare hydrothermal graphite deposit with the potential to produce a natural, high-purity graphite that may compete in high-technology markets traditionally reserved for synthetic graphite.
The company's high crystallinity graphite can be upgraded without the use of aggressive acid (HF) or high temperature thermal treatment. Zen has developed an environmentally friendly metallurgical process flowsheet that consists of grinding, flotation and caustic treatment using sodium hydroxide. The company states that it has been able to achieve an extraordinary carbon purity result of >99.9 percent in bench-scale tests, using this proprietary and environmentally friendly purification process.
According to the Zen, current end uses for its graphene materials include composites (concrete, rubber and plastics), energy storage and environmental applications but many more are under development.
The latest ZEN Graphene news:
ZEN Graphene Solutions announces collaboration agreement on carbon aerogels with German Aerospace Center
Zen Graphene Solutions recently announced that it has signed a new research collaboration agreement with the Deutsches Zentrum für Luft- und Raumfahrt (“DLR”, the German Aerospace Center) to investigate the use of Albany Pure graphene-based nanomaterials in the fabrication of novel carbon aerogel composites.
The goal of this collaborative research project titled, “Development of Innovative Composites based on Carbon Aerogels”, is to develop electrode materials for new generation batteries and will build on the collaboration between ZEN, DLR and Dr. Lukas Bichler at the University of British Columbia‐Okanagan Campus (UBC-O) that was previously reported.
Royal Canadian Navy partners with ZEN Graphene and Evercloak to test graphene oxide dehumidification membrane technology
ZEN Graphene Solutions recently announced that the Naval Material Technology Management (NMTM) section of the Royal Canadian Navy (RCN) has partnered with ZEN and Evercloak as a testing organization, and has agreed to provide in-kind donations of test services from the Naval Engineering Test Establishment (NETE).
The tests will compare the efficiency of an HVAC unit produced with the Evercloak dehumidification membrane technology to the incumbent HVAC system that is currently in use on the RCN’s Halifax-class frigates.
ZEN Graphene Solutions has reported that it has developed a novel graphene-based virucidal ink with 99% effectiveness against COVID-19. ZEN’s Virucidal ink was reportedly also 99% effective a minimum of 35 days after application to N95 mask material.
ZEN is now developing plans to expedite commercialization of this product, pending regulatory approval, and has filed a provisional patent for this graphene-based virucidal product.
ZEN Graphene Solutions recently reported that industry and university laboratories fully re-opened in late July-early August after a 4 month hiatus due to the Covid-19 pandemic and they have re-started ZEN’s collaborative R&D programs.
In addition, ZEN announced the recent award of two NSERC Alliance COVID-19 project grants, a Mitacs Elevate Postdoctoral Fellowship grant, and two Mitacs Accelerate grants for a total of CAD$355,000 (around USD$269,500) to its university collaborators increasing ZEN’s total research and development budget for the next 12 months to over CAD$1.4 Million (around USD$1.06 Miliion).
ZEN Graphene Solutions has announced it has commenced collaborations with research teams at a number of personal protective equipment (PPE) manufacturers to incorporate ZEN’s virucidal graphene ink into commercial products, including masks, gloves, gowns and other clothing following Zen’s promising results for an antiviral, graphene-based ink formulation from The University of Western Ontario’s ImPaKT Facility, biosafety Level 3 lab.
The company continues to optimize its proprietary formulation for dosage and delivery mechanism for highest antiviral impact. The next phase of testing is currently underway at the ImPaKT Facility and includes a preferred mask fabric coated in ZEN’s virucidal ink exposed to and tested against the COVID-19 virus.